When evaluating the predictive value of vimentin, TP53, and podoplanin in patients with cervical cancer, it was found that the levels of mRNA expression of vimentin, TP53, and podoplanin were significantly increased in the carcinoma tissue compared to adjacent normal cervical tissues; the expression of vimentin, TP53 and podoplanin was found to be correlated with the survival of patients with cervical cancer, which indicates their role as valuable biomarkers for the diagnosis and treatment of cervical cancer [71]. The gene discussed is VIM; the disease is cervical carcinoma.